Deep research
About AHK-Cu (Copper Tripeptide)
AHK-Cu is a copper-binding tripeptide with the structure Ala-His-Lys complexed with a Cu(II) ion, yielding an approximate molecular weight of 403 Da. The histidine and lysine residues coordinate the copper ion through their imidazole and amino side chains, respectively, forming a stable 1:1 peptide-copper complex. AHK-Cu was identified through systematic screening of short peptide sequences for hair follicle-specific growth activity, distinguishing it from the more broadly acting GHK-Cu, which has widespread effects on skin remodeling and wound healing.
The mechanism of action centers on stimulation of dermal papilla cells (DPCs), the specialized mesenchymal cells at the base of each hair follicle that serve as the signaling center controlling hair growth. AHK-Cu activates DPCs to increase production of Vascular Endothelial Growth Factor (VEGF) by approximately 3.5-fold and Fibroblast Growth Factor 7 (FGF-7, also called Keratinocyte Growth Factor/KGF) by approximately 2.8-fold, as measured by ELISA in cultured human DPCs. VEGF promotes angiogenesis around the hair follicle, improving nutrient and oxygen delivery to the rapidly dividing hair matrix cells. FGF-7 acts directly on hair matrix keratinocytes to stimulate their proliferation, which determines both the rate of hair growth and the thickness of the hair shaft.
In human hair follicle organ culture studies, AHK-Cu increased follicle size by 44%, an effect comparable to the positive control minoxidil at 10 micromolar concentration. However, the mechanism is fundamentally different: minoxidil acts primarily as a vasodilator (opening potassium channels in vascular smooth muscle), while AHK-Cu works through growth factor-mediated signaling. This mechanistic distinction means AHK-Cu and minoxidil are complementary rather than redundant, and can be used together for additive benefit.
AHK-Cu extends the anagen (active growth) phase of the hair cycle while delaying the transition to catagen (regression). The hair cycle consists of anagen (2-7 years), catagen (2-3 weeks), telogen (2-3 months), and exogen (shedding). In androgenetic alopecia and aging, the anagen phase progressively shortens, producing thinner, shorter hairs with each cycle. By extending anagen duration, AHK-Cu allows follicles to produce thicker, longer hairs.
The copper ion itself plays an important biological role. Copper is a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin in the dermal sheath surrounding the hair follicle. It is also a cofactor for superoxide dismutase (SOD), providing antioxidant protection to follicular cells against oxidative stress, which is elevated in balding scalp tissue. The peptide backbone serves both as a delivery vehicle for copper and as an independent signaling molecule.
For topical application, AHK-Cu should be applied directly to the scalp, ideally to clean, dry skin for optimal absorption. Store the product at room temperature (15-25C) away from direct sunlight. The copper-peptide complex is stable in aqueous solution at pH 5-7 for extended periods. For best results, apply once or twice daily, concentrating on areas of thinning. Allow the product to absorb for at least 10 minutes before applying other hair products.
Safety observations for topical copper peptides are extensive. AHK-Cu does not cause systemic copper absorption at levels that would affect serum copper or ceruloplasmin. No skin sensitization, irritation, or photosensitivity has been reported in patch testing studies. The tripeptide is non-immunogenic due to its small size. It does not interfere with hormonal hair loss treatments (finasteride, dutasteride) and can be safely combined with minoxidil, ketoconazole shampoo, and microneedling protocols. No adverse effects on hair color, texture, or existing healthy follicles have been observed.
